These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9342061)

  • 1. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA.
    Mouton Y; Alfandari S; Valette M; Cartier F; Dellamonica P; Humbert G; Lang JM; Massip P; Mechali D; Leclercq P; Modai J; Portier H
    AIDS; 1997 Oct; 11(12):F101-5. PubMed ID: 9342061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution.
    Arici C; Ripamonti D; Ravasio V; Maggiolo F; Rizzi M; Finazzi MG; Suter F
    Int J STD AIDS; 2001 Sep; 12(9):573-81. PubMed ID: 11516366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in hospitalization costs, morbidity, disability, and mortality in patients with aids treated with protease inhibitors.
    Lavalle C; Aguilar JC; Peña F; Estrada-Aguilar JL; Aviña-Zubieta JA; Madrazo M
    Arch Med Res; 2000; 31(5):515-9. PubMed ID: 11179588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term impact of highly active antiretroviral therapy on HIV-related health care costs.
    Keiser P; Nassar N; Kvanli MB; Turner D; Smith JW; Skiest D
    J Acquir Immune Defic Syndr; 2001 May; 27(1):14-9. PubMed ID: 11404515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical resource utilization and cost of HIV-related care in the highly active antiretroviral therapy era at a University Clinic in Sweden.
    Ghatnekar O; Hjortsberg C; Gisslén M; Lindbäck S; Löthgren M
    Pharmacoeconomics; 2010; 28 Suppl 1():49-57. PubMed ID: 21182343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiretroviral therapy in HIV infection. Effects of the introduction of new drugs on health care expenditures, 1994-1999].
    Manfredi R; Fiacchi P; Riolo U; Chiodo F
    Recenti Prog Med; 2000 Sep; 91(9):425-9. PubMed ID: 11021163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in human immunodeficiency virus patient hospitalizations and nontraumatic mortality after adoption of highly active antiretroviral therapy.
    Baum SE; Morris JT; Gibbons RV; Cooper R
    Mil Med; 1999 Sep; 164(9):609-12. PubMed ID: 10495628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Chêne G; Binquet C; Moreau JF; Neau D; Pellegrin I; Malvy D; Ceccaldi J; Lacoste D; Dabis F
    AIDS; 1998 Dec; 12(17):2313-20. PubMed ID: 9863874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline in the AIDS and death rates in the EuroSIDA study: an observational study.
    Mocroft A; Ledergerber B; Katlama C; Kirk O; Reiss P; d'Arminio Monforte A; Knysz B; Dietrich M; Phillips AN; Lundgren JD;
    Lancet; 2003 Jul; 362(9377):22-9. PubMed ID: 12853195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection.
    d'Arminio Monforte A; Testa L; Adorni F; Chiesa E; Bini T; Moscatelli GC; Abeli C; Rusconi S; Sollima S; Balotta C; Musicco M; Galli M; Moroni M
    AIDS; 1998 Sep; 12(13):1631-7. PubMed ID: 9764782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The affordability of antiretroviral therapy in developing countries: what policymakers need to know.
    Forsythe SS
    AIDS; 1998; 12 Suppl 2():S11-8. PubMed ID: 9792357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting HIV care costs using CD4 counts from clinical trials.
    Hill A; Gebo K
    Am J Manag Care; 2007 Sep; 13(9):524-8. PubMed ID: 17803366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico.
    Bautista-Arredondo S; Mane A; Bertozzi SM
    AIDS; 2006 Jan; 20(1):101-9. PubMed ID: 16327325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief communication: economic comparison of opportunistic infection management with antiretroviral treatment in people living with HIV/AIDS presenting at an NGO clinic in Bangalore, India.
    John KR; Rajagopalan N; Madhuri KV
    MedGenMed; 2006 Nov; 8(4):24. PubMed ID: 17415293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A French lesson. French experience shows full funding of treatment advances saves money.
    Alcorn K
    J Int Assoc Physicians AIDS Care; 1997 Apr; 3(4):49. PubMed ID: 11364203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001.
    Beck EJ; Mandalia S; Gaudreault M; Brewer C; Zowall H; Gilmore N; Klein MB; Lalonde R; Piché A; Hankins CA
    AIDS; 2004 Dec; 18(18):2411-8. PubMed ID: 15622317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of antiretroviral therapy adherence and health care costs.
    Nachega JB; Leisegang R; Bishai D; Nguyen H; Hislop M; Cleary S; Regensberg L; Maartens G
    Ann Intern Med; 2010 Jan; 152(1):18-25. PubMed ID: 20048268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of delaying or preventing AIDS in persons with HIV.
    Pinkerton SD; Holtgrave DR
    Am J Manag Care; 1999 Mar; 5(3):289-98. PubMed ID: 10351025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
    Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
    PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.